Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Recruiting · NCT06058988 · Registry updated 2026-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, astrocytoma (excluding glioblastoma), brain cancer, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, metastatic malignant neoplasm, neoplasm, neoplastic meningitis, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor, tumor of meninges | Recruiting | Phase 2 | 2026-02-23 | NCT06058988 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Memorial Sloan Kettering Cancer Center | 753 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |